Successful systemic high-dose ribavirin treatment of respiratory syncytial virus-induced infections occurring pre-engraftment in allogeneic hematopoietic stem cell transplant recipients

Transplant Infectious Disease

Volumn 15, Issue 4, 2013, Pages 435-440

  Gueller, S ^a   Duenzinger, U ^a   Wolf, T ^a   Ajib, S ^a   Mousset, S ^a   Berger, A ^a   Martin, H ^a   Serve, H ^a   Bug, G ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

Hematopoietic stem cell transplant; HSCT; Respiratory syncytial virus; Respiratory tract infection; Ribavirin; RSV

Indexed keywords

CYCLOSPORIN A; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RIBAVIRIN; THYMOCYTE ANTIBODY;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ANTIVIRAL THERAPY; ARTICLE; BRONCHIOLITIS OBLITERANS; CLINICAL ARTICLE; DRUG EFFICACY; GRAFT VERSUS HOST REACTION; HUMAN; NEUTROPENIA; NEUTROPHIL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PSEUDOMONAS PNEUMONIA; RESPIRATORY SYNCYTIAL VIRUS INFECTION; RETROSPECTIVE STUDY; SEPTIC SHOCK; THROAT CULTURE;

EID: 84880806823     PISSN: 13982273     EISSN: 13993062     Source Type: Journal    
DOI: 10.1111/tid.12092     Document Type: Article

References (29)

1. Whimbey E, Champlin RE, Couch RB, et al. Community respiratory virus infections among hospitalized adult bone marrow transplant recipients. Clin Infect Dis 1996; 22 (5): 778-782.
2. Khanna N, Widmer AF, Decker M, et al. Respiratory syncytial virus infection in patients with haematological diseases: single-center study and review of the literature. Clin Infect Dis 2008; 46 (3): 402-412.
3. Raboni SM, Nogueira MB, Tsuchiya LR, et al. Respiratory tract viral infections in bone marrow transplant patients. Transplantation 2003; 76 (1): 142-146.
4. Martino R, Porras RP, Rabella N, et al. Prospective study of the incidence, clinical features, and outcome of symptomatic upper and lower respiratory tract infections by respiratory viruses in adult recipients of hematopoietic stem cell transplants for hematologic malignancies. Biol Blood Marrow Transplant 2005; 11 (10): 781-796.
5. Schiffer JT, Kirby K, Sandmaier B, Storb R, Corey L, Boeckh M. Timing and severity of community acquired respiratory virus infections after myeloablative versus non-myeloablative hematopoietic stem cell transplantation. Haematologica 2009; 94 (8): 1101-1108.
6. Peck AJ, Englund JA, Kuypers J, et al. Respiratory virus infection among hematopoietic cell transplant recipients: evidence for asymptomatic parainfluenza virus infection. Blood 2007; 110 (5): 1681-1688.
7. Chemaly RF, Ghosh S, Bodey GP, et al. Respiratory viral infections in adults with hematologic malignancies and human stem cell transplantation recipients: a retrospective study at a major cancer center. Medicine (Baltimore) 2006; 85 (5): 278-287.
8. Ljungman P, Ward KN, Crooks BN, et al. Respiratory virus infections after stem cell transplantation: a prospective study from the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant 2001; 28 (5): 479-484.
9. Boeckh M, Berrey MM, Bowden RA, Crawford SW, Balsley J, Corey L. Phase 1 evaluation of the respiratory syncytial virus-specific monoclonal antibody palivizumab in recipients of hematopoietic stem cell transplants. J Infect Dis 2001; 184 (3): 350-354.
10. Boeckh M, Englund J, Li Y, et al. Randomized controlled multicenter trial of aerosolized ribavirin for respiratory syncytial virus upper respiratory tract infection in hematopoietic cell transplant recipients: NIAID Collaborative Antiviral Study Group. Clin Infect Dis 2007; 44 (2): 245-249.
11. McCarthy AJ, Kingman HM, Kelly C, et al. The outcome of 26 patients with respiratory syncytial virus infection following allogeneic stem cell transplantation. Bone Marrow Transplant 1999; 24 (12): 1315-1322.
12. Harrington RD, Hooton TM, Hackman RC, et al. An outbreak of respiratory syncytial virus in a bone marrow transplant center. J Infect Dis 1992; 165 (6): 987-993.
13. Lewinsohn DM, Bowden RA, Mattson D, Crawford SW. Phase I study of intravenous ribavirin treatment of respiratory syncytial virus pneumonia after marrow transplantation. Antimicrob Agents Chemother 1996; 40 (11): 2555-2557.
14. Machado CM, Boas LS, Mendes AV, et al. Low mortality rates related to respiratory virus infections after bone marrow transplantation. Bone Marrow Transplant 2003; 31 (8): 695-700.
15. Shah JN, Chemaly RF. Management of RSV infections in adult recipients of hematopoietic stem cell transplantation. Blood 2011; 117 (10): 2755-2763. Epub 7 Dec 2010.
16. Hall CB. Ribavirin: beginning the blitz on respiratory viruses? Pediatr Infect Dis 1985; 4 (6): 668-671.
17. Hall CB, McBride JT, Gala CL, Hildreth SW, Schnabel KC. Ribavirin treatment of respiratory syncytial viral infection in infants with underlying cardiopulmonary disease. JAMA 1985; 254 (21): 3047-3051.
18. Hall CB, McBride JT, Walsh EE, et al. Aerosolized ribavirin treatment of infants with respiratory syncytial viral infection: a randomized double-blind study. N Engl J Med 1983; 308 (24): 1443-1447.
19. Rodriguez WJ, Bui RH, Connor JD, et al. Environmental exposure of primary care personnel to ribavirin aerosol when supervising treatment of infants with respiratory syncytial virus infections. Antimicrob Agents Chemother 1987; 31 (7): 1143-1146.
20. Sparrelid E, Ljungman P, Ekelöf-Andström E, et al. Ribavirin therapy in bone marrow transplant recipients with viral respiratory tract infections. Bone Marrow Transplant 1997; 19 (9): 905-908.
21. Schleuning M, Buxbaum-Conradi H, Jäger G, Kolb HJ. Intravenous ribavirin for eradication of respiratory syncytial virus (RSV) and adenovirus isolates from the respiratory and/or gastrointestinal tract in recipients of allogeneic hematopoietic stem cell transplants. Hematol J 2004; 5 (2): 135-144.
22. Mentel R, Wegner U, Bruns R, Gürtler L. Real-time PCR to improve the diagnosis of respiratory syncytial virus infection. J Med Microbiol 2003; 52 (Pt 10): 893-896.
23. Dudek AZ, Mahaseth H. Hematopoietic stem cell transplant-related airflow obstruction. Curr Opin Oncol 2006; 18 (2): 115-119.
24. Nichols WG, Gooley T, Boeckh M. Community acquired respiratory syncytial virus and parainfluenza virus infections after hematopoietic stem cell transplantation: the Fred Hutchinson Cancer Research Center experience. Biol Blood Marrow Transplant 2001; 7 (Suppl): 11S-15S.
25. Ghosh S, Champlin RE, Englund J, et al. Respiratory syncytial virus upper respiratory tract illnesses in adult blood and marrow transplant recipients: combination therapy with aerosolized ribavirin and intravenous immunoglobulin. Bone Marrow Transplant 2000; 25 (7): 751-755.
26. Chakrabarti S, Collingham KE, Holder K, et al. Preemptive oral ribavirin therapy of paramyxovirus infections after haematopoietic stem cell transplantation: a pilot study. Bone Marrow Transplant 2001; 28: 759-763.
27. Avetisyan G, Mattsson J, Sparrelid E, Ljungman P. Respiratory syncytial virus infection in recipients of allogeneic stem-cell transplantation: a retrospective study of the incidence, clinical features, and outcome. Transplantation 2009; 88 (10): 1222-1226.
28. Chakrabarti S, Avivi I, Mackinnon S, et al. Respiratory virus infections in transplant recipients after reduced-intensity conditioning with Campath-1H: high incidence but low mortality. Br J Haematol 2002; 119 (4): 1125-1132.
29. Hirsch HH, Martino R, Ward KN, Boeckh M, Einsele H, Ljungman P. Fourth European Conference on Infections in Leukaemia (ECIL-4): guidelines for diagnosis and treatment of human respiratory syncytial virus, parainfluenzavirus, metapneumovirus, rhinovirus, and coronavirus. Clin Infect Dis 2013; 56 (2): 258-266. Epub 28 Sept 2012.